Synergetics USA, Inc. (NASDAQ: SURG) announced today that the Company will present at the Midwest IDEAS Conference on Wednesday, August 31, 2011, at the University of Chicago’s Gleacher Center in Chicago, Illinois. Synergetics’ presentation is scheduled to begin at 3:40 p.m. CDT (4:40 p.m. EDT). The presentation will be webcast live and may be accessed at the conference website,
, or in the investor relations section of the company’s website:
Meeting with investors will be Synergetics’ senior management team, including David M. Hable, President and Chief Executive Officer; Pamela G. Boone, Executive Vice President and Chief Financial Officer; and Jason Stroisch, Vice President of Marketing and International Sales.
The IDEAS investor conferences are annual independent venues allowing quality public companies to tell their stories to professional investors with the express purpose of generating investor interest. The IDEAS Investor Conferences are held annually in Boston, Chicago and Dallas and are produced by Three Part Advisors, LLC with sponsorships from the regional investment communities in which they are held. Additional information about the events can be located at
About Synergetics USA, Inc.
Through continuous improvement and development of our people, our mission is to design, manufacture and market innovative microsurgical devices, capital equipment, accessories and disposables of the highest quality in order to enable surgeons who perform microsurgery around the world to provide a better quality of life for their patients.
Synergetics USA, Inc. is a leading supplier of precision microsurgical devices. The Company’s primary focus is on the microsurgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company’s product lines focus upon precision engineered, microsurgical, hand-held instruments and the delivery of various energy modalities for the performance of less invasive microsurgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency energy for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company’s website address is
Some statements in this release may be “forward-looking statements” for the purposes of the Private Securities Litigation Reform Act of 1995.
In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions.
Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.
These factors, risks and uncertainties are discussed in Synergetics’ Annual Report on Form 10-K for the year ended July 31, 2010, as updated from time to time in our filings with the Securities and Exchange Commission.